In patients with hypertension, Ednra can increase vasoconstrictive tension, which may be related to the increase in ET-1 [35], and the use of endothelin receptor antagonists can significantly improve the target organ damage caused by EH [36]. The gene discussed is EDN1; the disease is hypertensive disorder.